Norwich Ventures is a specialized VC firm focused on early-stage MedTech.
Norwich Ventures is a specialized venture capital firm focused on early-stage medtech. We invest in entrepreneurs developing game-changing technologies that solve large unmet medical needs. We provide initial capital in seed and early-stage rounds. We approach each investment with a long-term perspective and continue to support and invest in the company throughout its phases of growth.
Announced Date | Fund Name | Money Raised | |
---|---|---|---|
Aug 12, 2013 | Norwich Ventures | - |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 24, 2020
Ionpath
|
Series B | $18M | Biotechnology | — |
Aug 19, 2020
Podimetrics
|
Series B | $8M | Diabetes | — |
May 9, 2019
Podimetrics
|
Series B | $13.40M | Diabetes | Yes |
May 1, 2017
ReThink Medical
|
Series A | $3.50M | Health Care | — |
Feb 1, 2017
Affera, Inc.
|
Series A | — | Health Care | — |
Norwich Ventures has had 4 exits. Norwich Ventures most notable exits include Affera, Inc. , Pelvalon
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jan 10, 2022 | Affera, Inc. | M&A | Health Care | Detail |
Oct 13, 2021 | Pelvalon | M&A | Health Care | Detail |
Oct 8, 2012 | Rhythmia Medical | M&A | Biotechnology | Detail |
Jun 6, 2012 | Intelligent Bio-Systems | M&A | Biotechnology | Detail |